ConductScience.org, home

Paper9045902

Experimental studies on potentiation of the antitumor activity of 5-fluorouracil with 3'-azido-3'-deoxythymidine for the gastric cancer cell line MKN28 in vivo.

Yasuda C and 3 others. Jpn J Cancer Res, 1997. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Experimental studies on potentiation of the antitumor activity of 5-fluorouracil with 3'-azido-3'-deoxythymidine for the gastric cancer cell line MKN28 in vivo. Papers, record 9045902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9045902

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Experimental studies on potentiation of the antitumor activity of 5-fluorouracil with 3'-azido-3'-deoxythymidine for the gastric cancer cell line MKN28 in vivo.
PubMed
Journal
Jpn J Cancer Res
PubMed
Year
1997
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.33
iCite
Revised in PubMed
2019-05-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yasuda CC
2Kato MM
3Kuroda DD
4Ohyanagi HH

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
FluorouracilMajor topic
Stomach NeoplasmsMajor topic
ZidovudineMajor topic
Animals
Bromodeoxyuridine
Drug Synergism
Female
Humans
Mice
Mice, Inbred BALB C
Thymidine Kinase
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13501541Biologic modulation of 5-fluorouracil with high-dose leucovorin and combination chemotherapy of 5-fluorouracil and cisplatin in metastatic colorectal adenocarcinoma.NCI Monogr1987https://conductscience.org/library/papers/3501541PubMed
23523837Immunological determination of labeling index on human tumor tissue sections using monoclonal anti-BrdUrd antibody.Stain Technol1986https://conductscience.org/library/papers/3523837PubMed
33517242Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.J Clin Oncol1986https://conductscience.org/library/papers/3517242PubMed
43835252[Quantitative method of 5-fluorouracil and its metabolites in biological samples using high performance liquid chromatography].Yakugaku Zasshi1985https://conductscience.org/library/papers/3835252PubMed
57357507Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU)RNA.Cancer1980https://conductscience.org/library/papers/7357507PubMed
62813268Dose-ranging pharmacokinetics of zidovudine (azidothymidine) in the rat.Pharm Res1989https://conductscience.org/library/papers/2813268PubMed
76305486Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture.Cancer Res1983https://conductscience.org/library/papers/6305486PubMed
87037180Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.Cancer Treat Rep1982https://conductscience.org/library/papers/7037180PubMed
92430286Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/2430286PubMed
103466165Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/3466165PubMed
11830420Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil.Cancer Res1977https://conductscience.org/library/papers/830420PubMed
126973389Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil.Cancer Res1981https://conductscience.org/library/papers/6973389PubMed
137123245Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication.Science1982https://conductscience.org/library/papers/7123245PubMed
144143960Pyrimidine metabolism in man.N Engl J Med1973https://conductscience.org/library/papers/4143960PubMed
156173112In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.Cancer Res1982https://conductscience.org/library/papers/6173112PubMed
166867754Sequential methotrexate and 5-fluorouracil: mechanisms of synergy.Semin Oncol1983https://conductscience.org/library/papers/6867754PubMed
172025497AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells.Cancer Commun1991https://conductscience.org/library/papers/2025497PubMed
1823544525-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.Cancer Res1990https://conductscience.org/library/papers/2354452PubMed
194005834Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole.Cancer Res1985https://conductscience.org/library/papers/4005834PubMed
20178442Tumor-associated thymidine kinase in the sera of rats with transplanted hepatomas.Cancer Res1976https://conductscience.org/library/papers/178442PubMed

See all 24 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
34206772Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?Cancers (Basel)2021https://conductscience.org/library/papers/34206772PubMed
23674964Effect of 3`-Azido-3`-Deoxythymidine (AZT) on Telomerase Activity and Proliferation of HO-8910 Cell Line of Ovarian Cancer.Int J Biomed Sci2006https://conductscience.org/library/papers/23674964PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TYMS7298PubTator's text mininghttps://conductscience.org/library/genes/7298

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9045902

GET https://conductscience.org/api/papers/v1/9045902/references?page=2